Page 7 - Cell Engineering News Today

In proof-of-concept experiments, Johns Hopkins Medicine scientists say they have successfully cultivated human muscle stem cells capable of renewing themselves and repairing muscle tissue damage in mice, potentially advancing efforts to treat muscle injuries and muscle-wasting disorders in people.

In proof-of-concept experiments, Johns Hopkins Medicine scientists say they have successfully cultivated human muscle stem cells capable of renewing themselves and repairing muscle tissue damage in mice, potentially advancing efforts to treat muscle

HORIBA UK partners with academia to develop new methods for drug discovery and disease diagnosis.

Type-1 diabetes (T1D) is a chronic metabolic autoimmune disease where the patient's immune system destroys insulin-producing β-cells in the islet of Langerhans. The current treatment option is through frequent administration of exogenous insulin, where the patients must closely monitor the dosage. Patients often need islet transplantation when the β-cell destruction worsens, and the body cannot utilize exogenously administrated insulin. Islet transplantation is a form of cell therapy that...

MiGenTra appoints with Heidi Hunter, Petra Reinke and Shaheer Bardissi three highly distinguished international leaders in Science and Entrepreneurship to its Advisory Board.

BERLIN, Germany, and CAIRO, Egypt, March 02, 2022 / B3C newswire / -- MiGenTra appoints highly distinguished international leaders in Science and Entrepreneurship to its Advisory Board:Heidi Hunter, President Specialty Solutions Business at Cardinal Health, USPetra Reinke, Professor of Medicine and founding director...

/PRNewswire/ -- Phytolon, a growing startup company making natural food colorants, announced a partnership today with Ginkgo Bioworks (NYSE: DNA), the leading...

NSW is home to 4 of Australia’s top 10 universities, many of whom feature in the top 100 universities in the world and is also home to 37 per cent of the Australia’s...

The Australian state of New South Wales (NSW), home to the city of Sydney, highlighted its world-class health, medtech and R&D ecosystem at a VIP dinner event held at the Australia Pavilion at Expo 2020 Dubai.

“Given that new variants keep emerging, the vaccine will be adapted to those of them that will be circulating at the time of the vaccine production. The production technology allows constantly upgrading the vaccine to deal with viral mutations,” Vladimir Gusakov noted.